Mbx Biosciences, Inc. Common Stock Stock Prediction and Forecast [MBX]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 23 Sept 2025, 04:06 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Mbx Biosciences, Inc. Common Stock Stock Prediction and Forecast [MBX]](https://i.ytimg.com/vi/9qxZ_vJlpfc/hqdefault.jpg)
AI-generated source summary
The analysis assesses MBX Biosciences Inc. Common Stock. Since September 22, 2025, the system ranked the stock as "Hold/Accumulate" with a score of 0. The stock's shorter trend has broken through its ceiling, anticipating an increase in volatility. The longer-term, 3-month analysis projects a potential change of 2.32%, with returns ranging from -50.03% to -19.68%. The 12-month analysis suggests a -36.32% change. Based on these trends, a potential peak, per fan theory, is $21.63. The latest daily report shows a close at $20.00 with high volatility of 48.88%, increasing in volume. Signals indicate positive buy signals for both the short and long term, yet there is a general sell signal because the long-term average is above the short-term. The analysis recommends a stop-loss at $19.26, a 3.70% decline, and suggests holding/accumulating.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.